INTRODUCTION
After a new diagnosis of localized PCa, treatment options may range from
AS to radical surgery in most cases.1 Patients are
often encouraged to take a second opinion before they decide for the
final treatment but this decision-making process could prolong the
duration between the diagnosis and potential treatment. The current
evidence on the impact of this waiting gap on the surgical and
oncological outcomes of the localized PCa is
conflicting.2, 3
The Covid-19 pandemic clearly delayed the surgical procedures due to
overwhelming case load of infected patients in healthcare systems. Due
to rapidly changing healthcare circumstances European Urological
Association (EAU) and some national associations including Turkish
Urooncology Association published recommendations during the pandemic
and suggested a delay for definitive surgical treatment of PCa, between
3 to 6 months with respect to the risk groups of
patients.4 Based on these recommendations, we aimed to
assess the possible impact of the time duration between diagnosis and
radical prostatectomy (RP) on the surgical and oncological outcomes of
the disease.